Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein

Authors: Exner, Markus1; Hermann, Marcela2; Hofbauer, Roland1; Kapiotis, Stylianos3; Quehenberger, Peter1; Speiser, Wolfgang1; Held, Irmtraud4; Gmeiner, Bernhard4

Source: Free Radical Research, Volume 34, Number 1, 2001 , pp. 101-112(12)

Publisher: Informa Healthcare

Buy & download fulltext article:

OR

Price: $42.29 plus tax (Refund Policy)

Abstract:

Hyperglycemia has been assumed to be responsible for oxidative stress in diabetes. In this respect, glucose autoxidation and advanced glycation end products (AGE) may play a causal role in the etiology of diabetic complications as e.g. atherosclerosis. There is now growing evidence that the oxidative modification of LDL plays a potential role in atherogenesis. Glucose derived oxidants have been shown to peroxidise LDL. In the present study, genistein, a compound derived from soy with a flavonoid chemical structure (4′, 5, 7-trihydroxyisoflavone) has been evaluated for its ability to act as an antioxidant against the atherogenic modification of LDL by glucose autoxidation radical products. Daidzein, (4′, 7-dihydroxyisoflavone) an other phytoestrogen of soy, was tested in parallel. Genistein — in contrast to daidzein — effectively prevented the glucose mediated LDL oxidation as measured by thiobarbituric acid-reactive substance formation (TBARS), alteration in electrophoretic mobility, lipid hydroperoxides and fluorescence quenching of tryptophan residues of the lipoprotein. In addition the potential of glucose-oxidized LDL to increase tissue factor (TF) synthesis in human endothelial cells (HUVEC) was completely inhibited when genistein was present during LDL oxidative modification by glucose. Both phytoestrogens did not influence the nonenzymatic protein glycation reaction as measured by the in vitro formation of glycated LDL. As the protective effect of genistein on LDL atherogenic modification was found at glucose/genistein molar ratios which may occur in vivo, our findings support the suggested beneficial action of a soy diet in preventing chronic vascular diseases and early atherogenic events.

Keywords: glucose autoxidation; LDL oxidation; genistein; daidzein; soy phytoestrogen

Document Type: Research article

DOI: http://dx.doi.org/10.1080/10715760100300101

Affiliations: 1: Department of Laboratory Medicine, University of Vienna 2: Institute of Molecular Genetics, University of Vienna 3: Department of Laboratory Medicine Krankenhaus Neunkirchen, Austria 4: Institute of Medical Chemistry, University of Vienna

Publication date: 2001-01-01

More about this publication?

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page